SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-298560
Filing Date
2022-12-05
Accepted
2022-12-05 17:27:10
Documents
12
Period of Report
2022-12-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d422148d8k.htm   iXBRL 8-K 23322
  Complete submission text file 0001193125-22-298560.txt   144434

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rna-20221201.xsd EX-101.SCH 2880
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rna-20221201_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rna-20221201_pre.xml EX-101.PRE 11282
6 EXTRACTED XBRL INSTANCE DOCUMENT d422148d8k_htm.xml XML 3361
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39321 | Film No.: 221445928
SIC: 2834 Pharmaceutical Preparations